Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Modulim
company
About
Light based technology sees beyond the visual, bringing exciting new insights to research, aesthetics and medicine.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.20M
- Industries
- Market Research,Product Research
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Modulim is a leader in a breakthrough technology in tissue and vascular assessment,called, spatial frequency domain imaging or SFDI. Powered by SFDI, our Clarifi Imaging System helps identify patients at risk of complications such as diabetic foot ulcers and amputations due to potential compromised circulation so clinicians can provide more timely intervention and save patients' limbs and lives.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$8.20M
Modulim has raised a total of
$8.20M
in funding over 2 rounds. Their latest funding was raised on
Jan 23, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 23, 2019 | Series B | $7M | 1 | — | — | Detail |
| Nov 20, 2017 | Grant | $1.20M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Modulim is funded by 2 investors.
National Institutes of Health
and Fouse KK
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
